Cargando…

Adverse Events and Healthcare Utilization Associated With Outpatient Parenteral Antimicrobial Therapy Among Older Versus Younger Adults

Among older (n = 204) versus younger (n = 253) adults, there was no difference in adverse events (adjusted odds ratio [aOR] = 0.98; 95% confidence interval [CI] = 0.6–1.6) or healthcare utilization (incidence rate ratio = 1.09; 95% CI = 0.9–1.3) within 30 days after discontinuing outpatient parenter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brzozowski, Kaylen, Datta, Rupak, Canterino, Joseph, Malinis, Maricar, Juthani-Mehta, Manisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566523/ https://www.ncbi.nlm.nih.gov/pubmed/33094112 http://dx.doi.org/10.1093/ofid/ofaa358

Ejemplares similares

1932. Healthcare Utilization in Older vs. Younger Adults on Outpatient Parenteral Antimicrobial Therapy According to Discharge Location
por: Datta, Rupak, et al.
Publicado: (2018)

1930. Developing an Electronic Medical Record System to Monitor Patients on Outpatient Parenteral Antibiotic Therapy at an Academic Medical Center
por: Canterino, Joseph, et al.
Publicado: (2018)

254. Antimicrobial Use in Hospitalized Older Patients with Advanced Cancer
por: Zhu, Mojun, et al.
Publicado: (2018)

Burden and Management of Multidrug-Resistant Organisms in Palliative Care
por: Datta, Rupak, et al.
Publicado: (2017)

249. Frequency of Antimicrobial Complications Following Initiation of Palliative Chemotherapy in Advanced Cancer Patients
por: Datta, Rupak, et al.
Publicado: (2018)

Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy
por: Underwood, Jonathan, et al.
Publicado: (2019)

101. Serious Adverse Event Rates for Cefazolin and Ceftriaxone Outpatient Parenteral Antimicrobial Therapy
por: Sunagawa, Shawnalyn, et al.
Publicado: (2023)

613. Clinical Outcomes Following Dalbavancin Administration during Outpatient Parenteral Antimicrobial Therapy
por: Tuan, Jessica, et al.
Publicado: (2021)

Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy
por: Tuan, Jessica J., et al.
Publicado: (2022)

248. Antimicrobial Therapy for Suspected Urinary Tract Infection in Advanced Cancer Patients Transitioning to Comfort Measures
por: Wang, Tianyun, et al.
Publicado: (2018)

Evaluating the Risk of Viral Myocarditis following Influenza Infection among Hospitalized Patients during 2014–2015 and 2015–2016 Influenza Seasons
por: Helou, Elie, et al.
Publicado: (2017)

2678. Characterizing Hospitalizations and Infections Among Older Adults Receiving Palliative Chemotherapy for Hematologic Malignancies
por: Uy, Natalie, et al.
Publicado: (2019)

760 Piperacillin/Tazobactam-Induced Adverse Drug Events in Pediatric Patients on Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Yusef, Dawood, et al.
Publicado: (2014)

Predictors of adverse safety events and unscheduled care among an outpatient parenteral antimicrobial therapy (OPAT) patient cohort
por: Billmeyer, Kaylyn N., et al.
Publicado: (2023)

Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases
por: Datta, Rupak, et al.
Publicado: (2018)

OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020)

Outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R, et al.
Publicado: (2023)

1832. Concordance in End-of-Life Antimicrobial Prescribing Practices among Medicine Subspecialists
por: Datta, Rupak, et al.
Publicado: (2018)

Serious adverse events of older adults in nursing home and community intervention trials
por: Datta, Rupak, et al.
Publicado: (2017)

Emergency Department Utilization During Self-Administered Outpatient Parenteral Antimicrobial Therapy
por: Ganguly, Anisha, et al.
Publicado: (2017)

162. Association Between Antibiotic Use and Multidrug-Resistant Organism Detection in Advanced Cancer Patients on Palliative Chemotherapy
por: Datta, Rupak, et al.
Publicado: (2018)

1935. Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Blaskewicz, Caitlin, et al.
Publicado: (2018)

Safety of Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Shrestha, Nabin K, et al.
Publicado: (2020)

Recommendations for outpatient parenteral antimicrobial therapy in Brazil
por: Oliveira, Priscila R., et al.
Publicado: (2017)

Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy
por: Mahoney, Monica V., et al.
Publicado: (2021)

Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy
por: Johnson, Tanner M., et al.
Publicado: (2023)

1925. Vancomycin Treatment and Time to Adverse Drug Reactions During Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Duncan, Asajah, et al.
Publicado: (2018)

Which Patients Discharged to Home-Based Outpatient Parenteral Antimicrobial Therapy Are at High Risk of Adverse Outcomes?
por: Keller, Sara C, et al.
Publicado: (2020)

604. Factors Associated with Adverse Drug Reactions Leading to Discontinuation of Vancomycin in Outpatient Parenteral Antimicrobial Therapy
por: McDonald, Josh, et al.
Publicado: (2020)

Design and analysis of longitudinal trials of antimicrobial use at the end of life: to give or not to give?
por: Juthani-Mehta, Manisha, et al.
Publicado: (2019)

2120. The Culture of Culturing Catheterized Patients: A Multi-Hospital Survey of Nurses and Physicians
por: Gao, Catherine, et al.
Publicado: (2018)

Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis
por: Pedersen, Maya Graham, et al.
Publicado: (2015)

Health-Related Quality of Life in Outpatient Parenteral Antimicrobial Therapy
por: Keller, Sara C, et al.
Publicado: (2018)

Risk Factors for Readmission in Patients with Outpatient Parenteral Antimicrobial Therapy
por: Huang, Victoria, et al.
Publicado: (2017)

1933. Economic Evaluation of Outpatient Parenteral Antimicrobial Therapy in Children
por: Krah, Nathan, et al.
Publicado: (2018)

Perspectives of Patients on Outpatient Parenteral Antimicrobial Therapy: Experiences and Adherence
por: Hamad, Yasir, et al.
Publicado: (2020)

Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis—Model of Care
por: Rajaratnam, Dylan, et al.
Publicado: (2023)

2171. Comparing Surveillance Definitions for Noncatheter-Associated Urinary Tract Infections
por: Datta, Rupak, et al.
Publicado: (2018)

1855. Antimicrobial Stewardship (AMS) and the Outpatient Parenteral Antimicrobial Therapy (OPAT) Setting
por: Friedman, N Deborah
Publicado: (2018)

121. Mucormycosis and COVID-19 in the United States: a Real-World Evidence Analysis of Risk Factors and Survival Among Patients with Mucormycosis, with and without COVID-19 Preceding the Infection
por: Brzozowski, Kaylen
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tre1kpu812gk3vn2oqvrieinv1